Dermal penetration and metabolism of p-aminophenol and p-phenylenediamine: application of the EpiDerm human reconstructed epidermis model.

To address the provision of the 7th Amendment to the EU Cosmetics Directive banning the use of in vivo genotoxicity assays for testing cosmetic ingredients in 2009, the 3D EpiDerm reconstructed human skin micronucleus assay has been developed. To further characterise the EpiDerm tissue for potential use in genotoxicity testing, we have evaluated the dermal penetration and metabolism of two hair dye ingredients, p-aminophenol (PAP) and p-phenylenediamine (PPD) in this reconstructed epidermis model. When EpiDerm tissue was topically exposed to PAP or PPD for 30 min (typical for a hair dye exposure), the majority (80->90%) of PAP or PPD was excluded from skin tissue and removed by rinsing. After a 23.5h recovery period, the PAP fraction that did penetrate was completely N-acetylated to acetaminophen (APAP). Similarly, 30 min topical application of PPD resulted in the formation of the N-mono- and N,N'-diacetylated metabolites of PPD. These results are consistent with published data on the dermal metabolism of these compounds from other in vitro systems as well as from in vivo studies. When tissue was exposed topically (PAP) or via the culture media (PPD) for 24h, there was good batch-to-batch and donor-to-donor reproducibility in the penetration and metabolism of PAP and PPD. Overall, the results demonstrate that these two aromatic amines are biotransformed in 3D EpiDerm tissue via N-acetylation. Characterising the metabolic capability of EpiDerm tissue is important for the evaluation of this model for use in genotoxicity testing.

[1]  L. Marrot,et al.  Development of genotoxicity test procedures with Episkin, a reconstructed human skin model: towards new tools for in vitro risk assessment of dermally applied compounds? , 2006, Mutation research.

[2]  K. Wittern,et al.  NAD(P)H:Quinone Reductase Activity in Human Epidermal Keratinocytes and Reconstructed Epidermal Models , 2002, Skin Pharmacology and Physiology.

[3]  G. Nohynek,et al.  Urinary acetylated metabolites and N-acetyltransferase-2 genotype in human subjects treated with a para-phenylenediamine-containing oxidative hair dye. , 2004, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[4]  Marilyn J Aardema,et al.  Development of a method for assessing micronucleus induction in a 3D human skin model (EpiDerm). , 2006, Mutation research.

[5]  John O Trent,et al.  Structure-function analyses of single nucleotide polymorphisms in human N-acetyltransferase 1. , 2008, Drug metabolism reviews.

[6]  G. Nohynek,et al.  Toxicity and human health risk of hair dyes. , 2004, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[7]  P. Lasserre,et al.  Percutaneous absorption of p‐phenylene diamine during an actual hair dyeing procedure , 1988, International journal of cosmetic science.

[8]  David A Basketter,et al.  In vitro skin irritation: facts and future. State of the art review of mechanisms and models. , 2004, Toxicology in vitro : an international journal published in association with BIBRA.

[9]  Mitchell Klausner,et al.  Further development of the EpiDerm 3D reconstructed human skin micronucleus (RSMN) assay. , 2009, Mutation research.

[10]  M. Relling,et al.  Nomenclature for N-acetyltransferases. , 1995, Pharmacogenetics.

[11]  K. Wittern,et al.  Comparison of Activities Dependent on Glutathione S-Transferase and Cytochrome P-450 IA1 in Cultured Keratinocytes and Reconstructed Epidermal Models , 2002, Skin Pharmacology and Physiology.

[12]  Arylamine N-acetyltransferases , 2007, Expert opinion on drug metabolism & toxicology.

[13]  Claus-Michael Lehr,et al.  Reconstructed Human Epidermis for Skin Absorption Testing: Results of the German Prevalidation Study , 2006, Alternatives to laboratory animals : ATLA.

[14]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[15]  M. Cottin,et al.  Improvement of the Experimental Setup to Assess Cutaneous Bioavailability on Human Skin Models: Dynamic Protocol , 2002, Skin Pharmacology and Physiology.

[16]  W Steiling,et al.  Percutaneous penetration/dermal absorption of hair dyes in vitro. , 2001, Toxicology in vitro : an international journal published in association with BIBRA.

[17]  David Kirkland,et al.  Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens III. Appropriate follow-up testing in vivo. , 2005, Mutation research.

[18]  Flamand Nicole,et al.  再構築ヒト皮膚モデル,Episkinによる遺伝毒性試験手順の開発:経皮適用化合物のin vitroでの危険性評価のための新しいツールか? , 2006 .

[19]  R. Roguet,et al.  The Use of Standardized Human Skin Models for Cutaneous Pharmacotoxicology Studies , 2002, Skin Pharmacology and Physiology.

[20]  F. Dreher,et al.  Comparison of Cutaneous Bioavailability of Cosmetic Preparations Containing Caffeine or α-Tocopherol Applied on Human Skin Models or Human Skin ex vivo at Finite Doses , 2002, Skin Pharmacology and Physiology.

[21]  H. Merk,et al.  N-Acetylation of paraphenylenediamine in human skin and keratinocytes. , 2000, The Journal of pharmacology and experimental therapeutics.

[22]  J. Cotovio,et al.  Effect of imidazole derivatives on cytochrome P-450 enzyme activities in a reconstructed human epidermis. , 1996, Skin pharmacology : the official journal of the Skin Pharmacology Society.

[23]  Lai-Hao Wang,et al.  Simultaneous determination of oxidative hair dye p-phenylenediamine and its metabolites in human and rabbit biological fluids. , 2003, Analytical biochemistry.

[24]  R. Roguet.  The Use of Reconstructed Human Epidermis EPISKIN™ in the Assessment of Local Tolerance of Cosmetics and Chemicals , 2004, Alternatives to laboratory animals : ATLA.

[25]  J. Thivolet,et al.  In vitro and post-transplantation differentiation of human keratinocytes grown on the human type IV collagen film of a bilayered dermal substitute. , 1991, Experimental cell research.

[26]  G. Nohynek,et al.  Human systemic exposure to a [14C]-para-phenylenediamine-containing oxidative hair dye and correlation with in vitro percutaneous absorption in human or pig skin. , 2004, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[27]  Lutz Müller,et al.  Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity. , 2005, Mutation research.

[28]  J. Southee,et al.  New epidermal model for dermal irritancy testing. , 1994, Toxicology in vitro : an international journal published in association with BIBRA.

[29]  C. Elcombe,et al.  Lack of evidence for metabolism of p-phenylenediamine by human hepatic cytochrome P450 enzymes. , 2005, Toxicology.

[30]  Lutz Müller,et al.  Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles. , 2006, Mutation research.

[31]  T. Sieber,et al.  Skin sensitization to p-phenylenediamine: the diverging roles of oxidation and N-acetylation for dendritic cell activation and the immune response. , 2009, The Journal of investigative dermatology.

[32]  M. Aardema,et al.  Intralaboratory and interlaboratory evaluation of the EpiDerm 3D human reconstructed skin micronucleus (RSMN) assay. , 2009, Mutation research.

[33]  R. Roguet,et al.  Permeation and Skin Absorption: Reproducibility of Various Industrial Reconstructed Human Skin Models , 2002, Skin Pharmacology and Physiology.

[34]  W. Dressler,et al.  Plasma/blood pharmacokinetics and metabolism after dermal exposure to para-aminophenol or para-phenylenediamine. , 2006, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[35]  G. Nohynek,et al.  Under the skin: Biotransformation of para-aminophenol and para-phenylenediamine in reconstructed human epidermis and human hepatocytes. , 2005, Toxicology letters.

[36]  Sue Gibbs,et al.  Xenobiotic metabolism in human skin and 3D human skin reconstructs: a review. , 2007, Current drug metabolism.